|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $171,386,282 | $205,021,181 | $367,992,648 | $318,567,436 | $239,797,773 | $300,064,532 | $272,560,608 |
| Streptomycins & their derivs.; salts thereof | $1,967,523 | $2,640,758 | $2,871,071 | $3,550,073 | $3,923,615 | $11,165,314 | $11,066,830 |
| Tetracyclines & their derivs.; salts thereof | $13,535,788 | $16,764,963 | $13,568,456 | $19,686,679 | $26,198,246 | $32,638,663 | $27,598,501 |
| Chloramphenicol & its derivs.; salts thereof | $6,074,270 | $6,640,663 | $7,122,435 | $7,165,271 | $6,042,875 | $7,646,208 | $6,809,972 |
| Erythromycin & its derivs.; salts thereof | $76,022,032 | $73,235,661 | $82,004,619 | $113,544,861 | $106,622,483 | $139,271,448 | $189,791,452 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $150,898,600 | $186,115,873 | $261,348,978 | $291,820,145 | $326,783,164 | $419,539,243 | $392,038,292 |
| Total | $419,884,495 | $490,419,099 | $734,908,207 | $754,334,465 | $709,368,156 | $910,325,408 | $899,865,655 |
|
|
